New York Life Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.65M Buy
21,906
+75
+0.3% +$19.4K 0.05% 307
2025
Q1
$4.89M Sell
21,831
-83
-0.4% -$18.6K 0.05% 323
2024
Q4
$5.01M Buy
21,914
+230
+1% +$52.6K 0.05% 324
2024
Q3
$5.29M Sell
21,684
-676
-3% -$165K 0.05% 335
2024
Q2
$4.28M Buy
22,360
+199
+0.9% +$38.1K 0.04% 374
2024
Q1
$4.39M Sell
22,161
-780
-3% -$154K 0.04% 371
2023
Q4
$3.95M Sell
22,941
-10,673
-32% -$1.84M 0.04% 378
2023
Q3
$4.97M Sell
33,614
-1,584
-5% -$234K 0.05% 308
2023
Q2
$7.69M Sell
35,198
-506
-1% -$111K 0.08% 235
2023
Q1
$7.82M Buy
35,704
+12,737
+55% +$2.79M 0.09% 235
2022
Q4
$4.78M Buy
22,967
+1
+0% +$208 0.05% 337
2022
Q3
$5.01M Sell
22,966
-100
-0.4% -$21.8K 0.06% 306
2022
Q2
$4.84M Buy
+23,066
New +$4.84M 0.06% 319